Implementation of the organoprotective properties of fixed combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with grade 2 and 3 hypertension in the Russian clinical study VICTORY II

Aim.Assessment of Vamloset and Co-Vamloset effects on blood pressure target levels and indicators associated with organ protection: albuminuria; elasticity of arteries and central aortic pressure (CAP); endothelial function; tumor necrosis factor-a, interleukin (IL) IL-6 and IL-10, vascular cell adh...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Irina E. Chazova, Tamila V. Martynyuk, Oleg V. Rodnenkov, Shurat B. Gorieva, Anatolii N. Rogoza, Mikhail V. Arkhipov, Yury I. Grinshtein, Olga D. Ostroumova, Albert S. Galiavich, Oxana P. Rotar’, Larisa A. Khaisheva, Tatiana R. Kameneva
Format:	article
Langue:	RU
Publié:	IP Morozov P.V. 2020
Sujets:	russian study victory ii arterial hypertension organ protection pulse wave velocity central arterial pressure central aortic pressure nephroprotection markers of endothelial damage ¬fixed combinations valsartan amlodipine hydrochlorothiazide vamloset® co-vamloset Diseases of the circulatory (Cardiovascular) system RC666-701
Accès en ligne:	https://doaj.org/article/749491d786994f6493162a7284467d61
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Soyez le premier à ajouter un commentaire!

Implementation of the organoprotective properties of fixed combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with grade 2 and 3 hypertension in the Russian clinical study VICTORY II

Documents similaires